» Authors » S Teipel

S Teipel

Explore the profile of S Teipel including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 362
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nemali A, Vockert N, Berron D, Maas A, Bernal J, Yakupov R, et al.
Med Image Anal . 2023 Sep; 90:102913. PMID: 37660483
Neuroimaging markers based on Magnetic Resonance Imaging (MRI) combined with various other measures (such as genetic covariates, biomarkers, vascular risk factors, neuropsychological tests etc.) might provide useful predictions of clinical...
2.
Konig A, Linz N, Baykara E, Troger J, Ritchie C, Saunders S, et al.
J Prev Alzheimers Dis . 2023 Mar; 10(2):314-321. PMID: 36946458
Background: Speech impairments are an early feature of Alzheimer's disease (AD) and consequently, analysing speech performance is a promising new digital biomarker for AD screening. Future clinical AD trials on...
3.
Wesselman L, van Lent D, Schroder A, van de Rest O, Peters O, Menne F, et al.
Eur J Nutr . 2020 May; 60(2):849-860. PMID: 32472387
Purpose: To investigate cross-sectional associations between dietary patterns and cognitive functioning in elderly free of dementia. Methods: Data of 389 participants from the German DELCODE study (52% female, 69 ± ...
4.
Stenzel J, Ruhlmann C, Lindner T, Polei S, Teipel S, Kurth J, et al.
Curr Alzheimer Res . 2018 Oct; 16(1):49-55. PMID: 30345916
Background: Positron-emission-tomography (PET) using 18F labeled florbetaben allows noninvasive in vivo-assessment of amyloid-beta (Aβ), a pathological hallmark of Alzheimer's disease (AD). In preclinical research, [F]-florbetaben-PET has already been used to...
5.
Zwingmann I, Hoffmann W, Michalowsky B, Wucherer D, Eichler T, Teipel S, et al.
Nervenarzt . 2018 Apr; 89(5):495-499. PMID: 29619534
Background: Results of current research studies revealed that providing informal care for people with dementia (PwD) is associated with caregivers' burden and a variety of health impairments. In order to...
6.
Kasper E, Ochmann S, Hoffmann W, Schneider W, Cavedo E, Hampel H, et al.
J Prev Alzheimers Dis . 2017 Dec; 2(2):142-152. PMID: 29231232
Within the last 20 years, several standardized cognitive trainings have been developed aiming at the delay of cognitive decline in older people who are at risk of Alzheimer's Disease (AD)...
7.
Zwingmann I, Hoffmann W, Michalowsky B, Dreier-Wolfgramm A, Hertel J, Wucherer D, et al.
Aging Ment Health . 2017 Nov; 22(7):889-896. PMID: 29156941
Objectives: Current research suggests that dementia care management (DCM) can decrease burden and associated health impairments of caregivers. The objective of this secondary analysis is to investigate the impact of...
8.
Wucherer D, Thyrian J, Eichler T, Hertel J, Kilimann I, Richter S, et al.
Int Psychogeriatr . 2017 Aug; 29(11):1857-1868. PMID: 28780910
Background: Older people have a higher risk of drug-related problems (DRPs). However, little is known about the prevalence of DRPs in community-dwelling people who screened positive for dementia. Our study...
9.
Cavedo E, Lista S, Khachaturian Z, Aisen P, Amouyel P, Herholz K, et al.
J Prev Alzheimers Dis . 2015 Oct; 1(3):181-202. PMID: 26478889
Alzheimer's disease (AD) is a slowly progressing non-linear dynamic brain disease in which pathophysiological abnormalities, detectable in vivo by biological markers, precede overt clinical symptoms by many years to decades....
10.
Kasper E, Thone-Otto A, Burger K, Schroder S, Hoffmann W, Schneider W, et al.
Nervenarzt . 2015 Sep; 87(7):708-18. PMID: 26391959
Background: Dementia impairs the coping with routine daily tasks and social relationships due to an increasing degeneration of cognitive abilities. An appropriate treatment must adequately consider the effects of declined...